Articles Vol. 67 No. CĐ6-NCKH 16/06/2026

INITIAL RESULTS OF LAPAROSCOPIC SINGLE-PORTION THYMECTOMY THYROIDECTOMY VIA SUPERHIZONTAL INCISION

Ngo Gia Khanh1,2, Dong Minh Hung1,2, Dang Thi Hoa1,2, Nguyen Minh Diep1,2, Mac The Truong1,2,3,4
1 Bach Mai Hospital
2 Bệnh viện Bạch Mai
3 Hanoi Medical University
4 Trường đại học Y Hà Nội
DOI: 10.52163/yhc.v67iCD6.5315
26 Views
0 Downloads
Keywords
Thymic adenoma, myasthenia gravis, single-port endoscopic surgery, subxiphoid process.
Abstract

Objectives: To evaluate the feasibility and early outcomes of subxiphoid uniportal video-assisted thoracoscopic surgery (VATS) for thymectomy in the treatment of myasthenia gravis and thymic tumors at Bach Mai Hospital.

Materials and Methods: A prospective case series study was conducted on patients indicated for subxiphoid uniportal VATS thymectomy at the Department of Thoracic Surgery, Bach Mai Hospital, from December 2024 to November 2025. Clinical indicators, histopathological characteristics, and early postoperative results were collected and analyzed.

Results: From December 2024 to November 2025, 39 patients (29 females and 10 males) underwent subxiphoid uniportal video-assisted thoracoscopic surgery thymectomy at Bach Mai Hospital. The mean age was 51.2 ± 13.1 years; 34 patients had myasthenia gravis (87.2%). The mean tumor size was 2.9 ± 1.2 cm. Histopathological results showed 7 cases of thymic hyperplasia (17.9%), 4 cases of benign thymic cysts (9.8%), and 28 cases of thymoma (71.8%), including: 2 cases of type A (7.1%), 9 cases of type AB (32.1%), 2 cases of type B1 (7.1%), 11 cases of type B2 (39.3%), and 4 cases of type B3 (14.3%). The mean operative time was 101.4 ± 23.8 minutes (range: 70–160 minutes). One case of intraoperative innominate vein injury occurred, but no conversion to open surgery was required. The mean chest tube duration was 2.1 ± 0.9 days, and the mean hospital stay was 5.0 ± 4.3 days. No patients experienced phrenic nerve palsy. Postoperative complications included one patient with pneumothorax requiring chest tube re-insertion and two patients with postoperative myasthenic crisis.

Conclusions: Subxiphoid uniportal VATS thymectomy is a safe and feasible technique for the treatment of myasthenia gravis and thymic tumors, yielding promising early outcomes at a specialized surgical center.

References
[1]
Kido T, Hazama K, Inoue Y, Tanaka Y et al. Resection of anterior mediastinal masses through an infrasternal approach. The Annals of Thoracic Surgery. 1999;67(1):263-265. doi:10.1016/S0003-4975(98)01210-7 Google Scholar
[2]
Suda T, Ishizawa H, Nagano H, et al. Early outcomes in 147 consecutive cases of subxiphoid single-port thymectomy and evaluation of learning curves. Eur J Cardiothorac Surg. 2020;58(Suppl_1):i44-i49. doi:10.1093/ejcts/ezaa183 Google Scholar
[3]
Chen H, Xu B, Zhang Q, Chen P et al. Anterior mediastinal tumor surgery applying single-port thoracoscopy using the subxiphoid approach. Turk Gogus Kalp Damar Cerrahisi Derg. 2023;31(2):239-248. doi:10.5606/tgkdc.dergisi.2023.23455 Google Scholar
[4]
Yu L, Zhang X jun, Ma S et al. Thoracoscopic thymectomy for myasthenia gravis with and without thymoma: a single-center experience. Ann Thorac Surg. 2012;93(1):240-244. doi:10.1016/j.athoracsur.2011.04.043 Google Scholar
[5]
Lê Thị Thiên Nga, Hồ Tất Bằng, Nguyễn Đình Phát et al. Kết quả bước đầu phẫu thuật nội soi lồng ngực cắt tuyến ức có kết hợp đường mổ dưới mũi ức. Tạp chí Y học Việt Nam. 2022;520(2):2. doi:10.51298/vmj.v520i2.4125 Google Scholar
[6]
Masaoka A. Staging System of Thymoma. Journal of Thoracic Oncology. 2010;5(10):S304-S312. doi:10.1097/JTO.0b013e3181f20c05 Google Scholar
[7]
Wolfe GI, Kaminski HJ, Aban IB, et al. Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med. 2016;375(6):511-522. doi:10.1056/NEJMoa1602489 Google Scholar
[8]
Perlo VP, Poskanzer DC, Schwab RS et al. Myasthenia gravis. Neurology. 1966;16(5):431-431. doi:10.1212/WNL.16.5.431 Google Scholar
[9]
Dresser L, Wlodarski R, Rezania K et al. Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. Journal of Clinical Medicine. 2021;10(11):11. doi:10.3390/jcm10112235 Google Scholar
[10]
Zhang L, Li M, Jiang F et al. Subxiphoid versus lateral intercostal approaches thoracoscopic thymectomy for non-myasthenic early-stage thymoma: A propensity score -matched analysis. International Journal of Surgery. 2019;67:13-17. doi:10.1016/j.ijsu.2019.01.011 Google Scholar
[11]
Detterbeck FC. Clinical Value of the WHO Classification System of Thymoma. The Annals of Thoracic Surgery. 2006;81(6):2328-2334. doi:10.1016/j.athoracsur.2005.11.067 Google Scholar
[12]
Tomiyama N, Johkoh T, Mihara N, et al. Using the World Health Organization Classification of Thymic Epithelial Neoplasms to Describe CT Findings. American Journal of Roentgenology. 2002;179(4):881-886. doi:10.2214/ajr.179.4.1790881 Google Scholar
[13]
Suda T. Subxiphoid thymectomy: single-port, dual-port, and robot-assisted. J Vis Surg. 2017;3:75. doi:10.21037/jovs.2017.05.07 Google Scholar
[14]
Jiang JH, Gao J, Zhang Y et al. Modified Subxiphoid Thoracoscopic Thymectomy for Locally Invasive Thymoma. Ann Thorac Surg. 2021;112(4):1095-1100. doi:10.1016/j.athoracsur.2020.10.032 Google Scholar
[15]
Wang H, Wang M, Xin N et al. Effect Evaluation of Subxiphoid and Intercostal Thymectomy: A Meta-Analysis and Systematic Review. Front Surg. 2022;9:925003. doi:10.3389/fsurg.2022.925003 Google Scholar
[16]
Rabiou S, Toudou-Daouda M, Lakranbi M et al. Outcomes after Thymectomy in Patients with Thymomatous Myasthenia Gravis. J Neurosci Rural Pract. 2022;13(2):321-325. doi:10.1055/s-0042-1743444 Google Scholar
[17]
Aljaafari D, Ishaque N. Thymectomy in Myasthenia Gravis: A Narrative Review. Saudi J Med Med Sci. 2022;10(2):97-104. doi:10.4103/sjmms.sjmms_80_22 Google Scholar